HK1073296A1 - Tumor imaging compounds - Google Patents
Tumor imaging compoundsInfo
- Publication number
- HK1073296A1 HK1073296A1 HK05106009.1A HK05106009A HK1073296A1 HK 1073296 A1 HK1073296 A1 HK 1073296A1 HK 05106009 A HK05106009 A HK 05106009A HK 1073296 A1 HK1073296 A1 HK 1073296A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- bromine
- iodine
- astatine
- compounds
- amino acid
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 238000003384 imaging method Methods 0.000 title 1
- -1 amino acid compounds Chemical class 0.000 abstract 4
- FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 abstract 3
- 150000002367 halogens Chemical group 0.000 abstract 2
- PNDPGZBMCMUPRI-HVTJNCQCSA-N 10043-66-0 Chemical compound [131I][131I] PNDPGZBMCMUPRI-HVTJNCQCSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-OIOBTWANSA-N Bromine-77 Chemical compound [77Br] WKBOTKDWSSQWDR-OIOBTWANSA-N 0.000 abstract 1
- ZCYVEMRRCGMTRW-AHCXROLUSA-N Iodine-123 Chemical compound [123I] ZCYVEMRRCGMTRW-AHCXROLUSA-N 0.000 abstract 1
- PNDPGZBMCMUPRI-XXSWNUTMSA-N [125I][125I] Chemical compound [125I][125I] PNDPGZBMCMUPRI-XXSWNUTMSA-N 0.000 abstract 1
- KRHYYFGTRYWZRS-BJUDXGSMSA-N ac1l2y5h Chemical compound [18FH] KRHYYFGTRYWZRS-BJUDXGSMSA-N 0.000 abstract 1
- CPELXLSAUQHCOX-AHCXROLUSA-N ac1l4zwb Chemical compound [76BrH] CPELXLSAUQHCOX-AHCXROLUSA-N 0.000 abstract 1
- 229910052789 astatine Inorganic materials 0.000 abstract 1
- RYXHOMYVWAEKHL-UHFFFAOYSA-N astatine atom Chemical compound [At] RYXHOMYVWAEKHL-UHFFFAOYSA-N 0.000 abstract 1
- RYXHOMYVWAEKHL-OUBTZVSYSA-N astatine-211 Chemical compound [211At] RYXHOMYVWAEKHL-OUBTZVSYSA-N 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- CPELXLSAUQHCOX-FTXFMUIASA-N bromine-75 Chemical compound [75BrH] CPELXLSAUQHCOX-FTXFMUIASA-N 0.000 abstract 1
- CPELXLSAUQHCOX-NJFSPNSNSA-N bromine-82 Chemical compound [82BrH] CPELXLSAUQHCOX-NJFSPNSNSA-N 0.000 abstract 1
- 230000009920 chelation Effects 0.000 abstract 1
- 238000002591 computed tomography Methods 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 239000012216 imaging agent Substances 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- XMBWDFGMSWQBCA-OIOBTWANSA-N iodane Chemical compound [124IH] XMBWDFGMSWQBCA-OIOBTWANSA-N 0.000 abstract 1
- 229940044173 iodine-125 Drugs 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000002600 positron emission tomography Methods 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 229910052702 rhenium Inorganic materials 0.000 abstract 1
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 abstract 1
- 229910052713 technetium Inorganic materials 0.000 abstract 1
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0487—Metallocenes, i.e. complexes based on a radioactive metal complexed by two cyclopentadienyl anions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/20—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37712402P | 2002-04-30 | 2002-04-30 | |
| PCT/US2003/012748 WO2003093412A2 (en) | 2002-04-30 | 2003-04-24 | Tumor imaging compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1073296A1 true HK1073296A1 (en) | 2005-09-30 |
Family
ID=29401448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK05106009.1A HK1073296A1 (en) | 2002-04-30 | 2005-07-14 | Tumor imaging compounds |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7544715B2 (ja) |
| EP (1) | EP1499584B1 (ja) |
| JP (2) | JP4611017B2 (ja) |
| KR (1) | KR100745445B1 (ja) |
| CN (2) | CN101041674A (ja) |
| AT (1) | ATE478041T1 (ja) |
| AU (1) | AU2003231758B2 (ja) |
| CA (1) | CA2479514C (ja) |
| DE (1) | DE60333830D1 (ja) |
| DK (1) | DK1499584T3 (ja) |
| ES (1) | ES2349528T3 (ja) |
| HK (1) | HK1073296A1 (ja) |
| NZ (1) | NZ535333A (ja) |
| WO (1) | WO2003093412A2 (ja) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060292073A1 (en) * | 2005-06-23 | 2006-12-28 | Emory University | Stereoselective Synthesis of Amino Acid Analogs for Tumor Imaging |
| US7837982B2 (en) | 2005-06-23 | 2010-11-23 | Emory University | Imaging agents |
| WO2007030571A2 (en) * | 2005-09-06 | 2007-03-15 | Molecular Image Inc. | Identification of targets and development of reagents for testing and molecular imaging of human disease |
| AU2007202205A1 (en) * | 2006-05-18 | 2007-12-06 | Deere & Company | Multi-prong conversion tine for a harvester reel |
| WO2007137135A2 (en) * | 2006-05-18 | 2007-11-29 | The Regents Of The University Of California | Rotenone analogs: method of preparation and use |
| WO2009045535A2 (en) * | 2007-10-04 | 2009-04-09 | Sloan-Kettering Institute For Cancer Research | Fluorine-18 derivative of dasatinib and uses thereof |
| US8246752B2 (en) | 2008-01-25 | 2012-08-21 | Clear Catheter Systems, Inc. | Methods and devices to clear obstructions from medical tubes |
| US20110033382A1 (en) | 2008-04-14 | 2011-02-10 | Emory University | Imaging Agents |
| US8722014B2 (en) * | 2009-05-01 | 2014-05-13 | Washington University | 1 H-[1, 2, 3] triazole substituted amino acids and uses thereof |
| CN101954097B (zh) * | 2009-07-14 | 2014-06-04 | 北京师范大学 | 新型18f标记取代苯并咪唑类化合物及其制备方法和制备肿瘤pet显像剂中的应用 |
| AU2011268129A1 (en) * | 2010-06-18 | 2013-01-10 | The Regents Of The University Of California | Isotopic labeling for the measurement of global protein levels and turnover in vivo |
| JP2014501702A (ja) | 2010-10-28 | 2014-01-23 | ジーイー・ヘルスケア・リミテッド | 放射性医薬品前駆体の安定化 |
| CA3034757A1 (en) | 2016-08-23 | 2018-03-01 | Simon Fraser University | 18f labeled amino acids, derivatives thereof and method of making same |
| EP3293167A1 (en) * | 2016-09-09 | 2018-03-14 | Université Catholique De Louvain | [18f]-labelled lactate derivative as pet radiotracer |
| KR102522843B1 (ko) * | 2017-11-21 | 2023-04-18 | 솔벡스 리미티드 라이어빌리티 컴퍼니 | 중수소화된 2-아미노-2-메틸프로피온산 및/또는 2-(n-메틸아미노)-2-메틸프로피온산을 포함하는, 종양성 질환의 자기공명진단을 위한 제제, 및 상기 제제를 이용한 진단방법 |
| JP6786194B2 (ja) * | 2018-12-05 | 2020-11-18 | 大塚化学株式会社 | 有機テルル化合物の製造方法およびビニル重合体の製造方法 |
| CN114163343A (zh) * | 2021-12-10 | 2022-03-11 | 许昌学院 | 含氟氨基酸及衍生物含氟多肽的制备方法以及应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3855208A (en) | 1971-05-24 | 1974-12-17 | Becton Dickinson Co | Derivatives of digoxigenin |
| US4695588A (en) | 1977-06-01 | 1987-09-22 | Merck & Co., Inc. | Fluorinated amino acids |
| US4325961A (en) | 1977-06-01 | 1982-04-20 | Merck & Co., Inc. | Fluorinated amino acids |
| US4743691A (en) | 1977-07-11 | 1988-05-10 | Merrell Dow France Et Cie | 2-halomethyl derivatives of 2-amino acids |
| US4483870A (en) | 1978-07-24 | 1984-11-20 | Merck & Co., Inc. | α-Difluoromethyl amino acids and hypertension treating compositions thereof |
| US4358434A (en) | 1979-12-19 | 1982-11-09 | New England Nuclear Corporation | Method, composition and kit for stabilizing radiolabeled compounds |
| US4390517A (en) | 1979-12-19 | 1983-06-28 | New England Nuclear Corporation | Method, composition and kit for stabilizing radiolabeled compounds |
| US4942231A (en) | 1984-05-24 | 1990-07-17 | Mallinckrodt, Inc. | Method of preparing a chlorinated, brominated, radio-brominated, iodinated and/or radioiodinated aromatic or heteroaromatic compound |
| US4760091A (en) | 1985-10-01 | 1988-07-26 | The Dow Chemical Company | Method of controlling phytopathogenic fungus |
| US5227467A (en) | 1987-08-03 | 1993-07-13 | Merck & Co., Inc. | Immunosuppressive fluorinated cyclosporin analogs |
| US5116599A (en) | 1989-07-31 | 1992-05-26 | Johns Hopkins Univ. | Perfluoro-t-butyl-containing compounds for use in fluorine-19 nmr and/or mri |
| CA2026377A1 (en) | 1989-10-03 | 1991-04-04 | John L. Krstenansky | Radiolabeled anticoagulant peptides |
| US5128118A (en) | 1990-08-09 | 1992-07-07 | Research Triangle Institute | Cocaine receptor binding ligands |
| US5698179A (en) | 1992-02-25 | 1997-12-16 | Neuro Imaging Technologies, Llc | Iodinated neuroprobe for mapping monoamine reuptake sites |
| US5310912A (en) | 1992-02-25 | 1994-05-10 | Research Biochemicals Limited Partnership | Iodinated neuroprobe for mapping monoamine reuptake sites |
| US5637759A (en) | 1992-07-30 | 1997-06-10 | The Regents Of The University Of California | Metal-ligating amino acid derivatives for MRI and for peptide synthesis |
| US5493026A (en) | 1993-10-25 | 1996-02-20 | Organix, Inc. | Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders |
| US5808146A (en) * | 1995-11-09 | 1998-09-15 | Emory University | Amino acid analogs for tumor imaging |
| FR2748475B1 (fr) | 1996-05-10 | 1999-04-16 | Cis Bio Int | Derives du tropane utilisables en particulier pour la detection in vivo des transporteurs de la dopamine |
| US6344179B1 (en) | 1999-04-22 | 2002-02-05 | Emory University | Fluoralkenyl nortropanes |
| EP1212103B1 (en) | 1999-04-26 | 2004-11-03 | Emory University | 4-fluoroalkyl-3-halophenyl nortropanes |
| US6843979B2 (en) | 1999-04-26 | 2005-01-18 | Emory University | 4-haloethenylphenyl tropane:serotonin transporter imaging agents |
| US6933042B2 (en) * | 2003-07-30 | 2005-08-23 | Hitachi Global Storage Technologies Netherlands B.V. | Ballistic GMR structure using nanoconstruction in self pinned layers |
-
2003
- 2003-04-24 US US10/507,221 patent/US7544715B2/en not_active Expired - Lifetime
- 2003-04-24 NZ NZ535333A patent/NZ535333A/en not_active IP Right Cessation
- 2003-04-24 DK DK03747599.3T patent/DK1499584T3/da active
- 2003-04-24 AT AT03747599T patent/ATE478041T1/de active
- 2003-04-24 AU AU2003231758A patent/AU2003231758B2/en not_active Ceased
- 2003-04-24 CN CNA2007100876699A patent/CN101041674A/zh active Pending
- 2003-04-24 ES ES03747599T patent/ES2349528T3/es not_active Expired - Lifetime
- 2003-04-24 EP EP03747599A patent/EP1499584B1/en not_active Expired - Lifetime
- 2003-04-24 KR KR1020047014825A patent/KR100745445B1/ko active IP Right Grant
- 2003-04-24 WO PCT/US2003/012748 patent/WO2003093412A2/en active Application Filing
- 2003-04-24 CA CA2479514A patent/CA2479514C/en not_active Expired - Fee Related
- 2003-04-24 CN CNB038098733A patent/CN1313436C/zh not_active Expired - Lifetime
- 2003-04-24 JP JP2004501548A patent/JP4611017B2/ja not_active Expired - Fee Related
- 2003-04-24 DE DE60333830T patent/DE60333830D1/de not_active Expired - Lifetime
-
2005
- 2005-07-14 HK HK05106009.1A patent/HK1073296A1/xx not_active IP Right Cessation
-
2009
- 2009-02-26 JP JP2009044923A patent/JP2009149678A/ja active Pending
- 2009-05-12 US US12/464,226 patent/US7989649B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005523941A (ja) | 2005-08-11 |
| CA2479514A1 (en) | 2003-11-13 |
| JP2009149678A (ja) | 2009-07-09 |
| ATE478041T1 (de) | 2010-09-15 |
| EP1499584A2 (en) | 2005-01-26 |
| AU2003231758B2 (en) | 2009-10-22 |
| CN1313436C (zh) | 2007-05-02 |
| CN101041674A (zh) | 2007-09-26 |
| US20050192458A1 (en) | 2005-09-01 |
| DE60333830D1 (de) | 2010-09-30 |
| US7989649B2 (en) | 2011-08-02 |
| US7544715B2 (en) | 2009-06-09 |
| AU2003231758A1 (en) | 2003-11-17 |
| EP1499584B1 (en) | 2010-08-18 |
| CA2479514C (en) | 2011-07-26 |
| ES2349528T3 (es) | 2011-01-04 |
| US20090240041A1 (en) | 2009-09-24 |
| CN1649828A (zh) | 2005-08-03 |
| KR20050005425A (ko) | 2005-01-13 |
| WO2003093412A2 (en) | 2003-11-13 |
| NZ535333A (en) | 2007-02-23 |
| EP1499584A4 (en) | 2007-08-15 |
| DK1499584T3 (da) | 2010-09-20 |
| KR100745445B1 (ko) | 2007-08-03 |
| WO2003093412A3 (en) | 2004-04-01 |
| JP4611017B2 (ja) | 2011-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1073296A1 (en) | Tumor imaging compounds | |
| WO2007001940A3 (en) | Imaging agents | |
| US20220135529A1 (en) | Metal/radiometal-labeled psma inhibitors for psma-targeted imaging and radiotherapy | |
| US20200282083A1 (en) | Psma-binding agents and uses thereof | |
| Wang et al. | Bioisosterism of urea-based GCPII inhibitors: synthesis and structure–activity relationship studies | |
| JP2020165975A (ja) | 陽電子放出断層撮影用の化合物 | |
| US11707539B2 (en) | FAP-targeted radiopharmaceuticals and imaging agents, and uses related thereto | |
| CA2237218A1 (en) | Amino acid analogs for tumor imaging | |
| WO2019177449A1 (es) | 177lu-dota-hynic-ipsma como un radiofármaco terapéutico dirigido al antígeno prostático específico de membrana | |
| US10196412B2 (en) | Probe for imaging PARP-1 activity | |
| US20240207292A1 (en) | Boronic acid compounds, compositions and methods | |
| Class et al. | Patent application title: METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY | |
| Tago et al. | Preliminary Evaluation of 2-Arylhydroxyquinoline Derivatives for Tau Imaging |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190422 |
|
| ARF | Application filed for restoration |
Effective date: 20200204 |
|
| ARG | Restoration of standard patent granted |
Effective date: 20200313 |
|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220424 |